Addiction

Compassion Center and SIDHE Calls for Urgent Action on Misleading and Dangerous Psychedelic Products Flooding the Market

Compassion Center and SIDHE sound the alarm on a growing crisis in the psychedelic market, warning consumers of dangerous, mislabeled…

1 year ago

Lin Health to Collaborate with Mayo Clinic to Expand Access to Evidence-Based, Tech-Enabled Chronic Pain Care

Retraining the brain's neural circuitry through a behavioral health approach empowers people living with chronic pain to avoid costly and…

1 year ago

Psych Hub Launches Behavioral Health Care Navigation Platform to Connect Consumers with Trusted Mental Health Resources

Leader in evidence-based provider training and consumer mental health education adds online care navigation service to help individuals find support…

1 year ago

Pasadena Villa Expands Mental Health Treatment Services With New Residential Facility in Michigan

BRENTWOOD, TN / ACCESSWIRE / October 22, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health, addiction, and…

1 year ago

Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites

Toronto, Ontario--(Newsfile Corp. - October 22, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

1 year ago

NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence

ZURICH, SWITZERLAND / ACCESSWIRE / October 21, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage…

1 year ago

Laguna Treatment Center Sets Standard for Veteran Addiction Care in Southern California with New PsychArmor Certification

ALISO VIEJO, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Laguna Treatment Center is among an elite group of addiction treatment…

1 year ago

Shoreline Recovery Center Educates Parents, Caretakers on the Danger of Encouraging Long-Term Patterns Towards Addiction

SAN DIEGO, CA / ACCESSWIRE / October 17, 2024 / Loved ones and caretakers have a critical role to play…

1 year ago

Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development

PsyLabs to exclusively supply Psyence Biomed with high purity, pharmaceutical grade psilocybin for its second development indication, Alcohol Use Disorder,…

1 year ago